The incidence of these outcomes has been shown to exceed that observed for obesity-related comorbidities alone
Reduces the risk of cardiovascular disease: Ozempic has been shown to reduce the risk of heart disease and stroke in patients with type 2 diabetes who are at high risk for these conditions
Tirzepatide Research on naturally occurring incretins isolated from some fish (e.g., lamprey, dogfish and paddlefish) has shown that they can act as dual agonist of the GLP-1, GIP, and glucagon receptors, to lower blood glucose levels and induce weight loss (reviewed in Conlon et al., 2022)
Retatrutide, by contrast, remains in Phase 3 clinical development as of 2026
Spontaneity On Your Schedule Effects begin within an hour and can last up to 72 hours, giving you the freedom and flexibility for intimacy
This results in more meaningful weight loss than Ozempic